Cytomegalovirus antibody status and renal transplantation: 1987-1994

Transplantation

Volumn 62, Issue 1, 1996, Pages 34-37

  Hirata, Masaru ^a   Terasaki, Paul I ^a   Cho, Yong W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CADAVER DONOR; CYTOMEGALOVIRUS; FEMALE; GRAFT SURVIVAL; HIGH RISK POPULATION; HLA MATCHING; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SEROCONVERSION; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; CADAVER; CONTINENTAL POPULATION GROUPS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TISSUE DONORS; UNITED STATES;

EID: 0029950276     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00007     Document Type: Article

References (16)

1. Simmons RL, Matas AJ, Ratazzi LC, Balfour HH Jr, Howard RJ, Najarian JS. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery 1977; 82: 537.
2. Peterson PK, Balfour HH, Marker SC, et al. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 1980; 59: 283.
3. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51: 98.
4. Ranjan D, Burke G, Esquenazi V, et al. Factors affecting the ten-year outcome of human renal allografts: the effect of viral infections. Transplantation 1991; 51: 113.
5. Terasaki PI, Yuge J, Cecka JM, Gjertson DW. Cytomegalovirus antibody status and kidney transplantation. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1995: 509.
6. Gjertson DW, Terasaki PI, Takemoto S, Mickey MR. National allocation of cadaveric kidneys by HLA matching: projected effect on outcome and costs. N Engl J Med 1991; 324: 1032.
7. Takemoto S, Terasaki PI, Gjertson GW, Cecka JM. Equitable allocation of HLA compatible kidney for local pools and for minorities. N Engl J Med 1994; 331: 760.
8. Rubin RH, Tolkoff-Rubin NE, Oliver D, et al. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243.
9. van Dorp WT, van Wieringen PA, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 1993; 55: 1367.
10. Mathiesen T, Collins VP, Ohlsson E, Sundqvist VA, Wahren B. Induction of MHC class I antigen expression following infection of a human esthesioneuroblastoma cell line with cytomegalovirus and human immunodeficiency virus. Acta Virol 1992; 36: 551.
11. Pouteil-Noble C, Ecochard R, Landrivon G, et al. Cytomegalovirus infection: an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 1993; 55: 851.
12. Hibberd PL, Tolkoff-Rubin NE, Cosmi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992; 53: 68.
13. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody positive renal transplant recipients. A randomized controlled trial. Ann Intern Med 1995; 123: 18.
14. Dunn DL, Mayoral JL, Gillingham KJ, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 1991; 51: 98.
15. Nicol DL, Macdonald AS, Belitsky P, et al. Reduction by combination prophylactic therapy with CMV hyperimmune globulin and acyclovir of the risk of primary CMV disease in renal transplant recipients. Transplantation 1993; 55: 841.
16. Conti DJ, Freed BM, Gruber SA, Lempert N. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients: a trial of ganciclovir vs. immunoglobulin. Arch Surg 1994; 129: 443.